For research use only
| Cat No. | ABC-TC3743 |
| Product Type | Female Reproductive Cells |
| Cell Type | Epithelial |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Ovarian |
| Disease | Normal |
| Storage | Liquid Nitrogen |
HOSECs from ovarian surface form cobblestone monolayers, express CK7, E-cadherin, hormone receptors, used for ovarian cancer and EMT research.
Human Ovarian Surface Epithelial Cells (HOSECs) are primary cells isolated from the outer layer of healthy human ovaries. In vivo, these cells display diverse morphologies, ranging from squamous to cuboidal to low columnar. HOSECs play a crucial role in ovarian physiology, including ovulation and repair of the ovarian surface following follicle rupture. HOSECs express key markers such as cytokeratin 8/18, E-cadherin, and CA-125. In addition, they express estrogen receptor alpha (ERα) and beta (ERβ), and progesterone receptor (PR), verified by immunostaining. When co-cultured with endometrial stromal cells under estrogen-rich conditions, these cells form gland-like structures. They are also significant in studying ovarian pathologies, as the ovarian surface epithelium is the origin of most epithelial ovarian cancers. These cells provide an ideal in vitro model for researching ovarian cancer initiation, epithelial-mesenchymal transition (EMT), and response to hormonal stimuli.
| Product Code | HOSEpiC |
| Species | Human |
| Cat.No | ABC-TC3743 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Ovarian |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Female Reproductive Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Human Ovarian Surface Epithelial Cells serve as a critical in vitro model for investigating the cellular and molecular mechanisms underlying the development of epithelial ovarian carcinoma (EOC), particularly high-grade serous carcinoma. Studies investigating the ovarian surface epithelium (OSE) and its morphological alterations following ovulation, as well as its involvement in the origin of epithelial ovarian carcinomas, are central to understanding ovarian tumorigenesis. Elucidating dysregulated signaling pathways that govern HOSEC survival, apoptosis, proliferation, and epithelial-to-mesenchymal transition (EMT) is of clinical relevance. These insights are critical for characterizing disease progression and for identifying molecular biomarkers that may inform early detection, therapeutic targeting, and personalized management of epithelial ovarian cancer.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
Human Ovarian Surface Epithelial Cells are the layer of cells that cover the surface of the ovary. They are involved in the ovulation process and are the origin of most ovarian cancers, making them significant in both reproductive biology and cancer research.
Human Ovarian Surface Epithelial Cells play a role in protecting the ovary and participate in the ovulation process by covering the ovarian surface. They also undergo cyclic changes in response to hormonal fluctuations and are involved in the repair of the ovarian surface after ovulation.
These cells are used in research to study ovarian biology, the mechanisms of ovulation, and the pathogenesis of ovarian cancer. They are also important for exploring the effects of hormones on ovarian function and for developing targeted therapies for ovarian cancer.
The majority of ovarian cancers are believed to originate from Human Ovarian Surface Epithelial Cells. Studying these cells can provide insights into the early events of ovarian carcinogenesis, helping to identify potential biomarkers and therapeutic targets for ovarian cancer.
Yes, Human Ovarian Surface Epithelial Cells can be used in drug screening, particularly for testing the effects of chemotherapeutic agents or targeted therapies on ovarian cells. They provide a relevant model for assessing the response of ovarian tissue to various treatments.